LEADERS FREE IV (RCT): BioFreedom™ Ultra vs BioFreedom™ in HBR Patients
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 444 participants.
Also called NCT06657326
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 444 participants
- Sponsor
- Registry
-
NCT06657326
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Malaysia
- Registry status
- Recruiting
Technical summary
Registry record NCT06657326. Randomized; single masking; primary purpose treatment. Start 2024-12-18 (actual); primary completion 2026-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- LEADERS FREE IV (RCT): BioFreedom™ Ultra vs BioFreedom™ in HBR Patients
- Condition
- Coronary Artery Disease
- Condition
- Chronic Stable Angina
- Condition
- Unstable Angina
- Condition
- Silent Ischemia
- Condition
- Acute Coronary Syndrome
- Intervention (Device)
- BioFreedom™ Ultra cobalt-chromium Biolimus A9™-coated stent
- Intervention (Device)
- BioFreedom™ stainless steel Biolimus A9™-coated stent
- Lead sponsor
- Biosensors Europe SA
Record details
- Record id
cardio:ct-nct06657326- Content hash
e460b3c6cfa06f525332ece32486e6b8d9e8af714a28a4d0ba0f3a7b331cad72